Senior Vice President of Platform
Atavistik Bio
Cambridge, Massachusetts
Tom Roddy has worked across many areas of the drug discovery pipeline over the past 20+ years, from pre-competitive academic collaborations through post-marketing studies. He is currently the Senior VP of Platform at Atavistik Bio, a biotech using a scalable approach to identify and harness highly conserved protein-metabolite interactions to discover novel regulatory allosteric sites for drug discovery.
Previously, he was the VP of Metabolism and Proteomics at Agios Pharmaceuticals and also led the start of the Agios' External Innovation. His career started at Genzyme and he has worked at other companies like Novartis Institutes for BioMedical Research, Merck, and Beryllium. He is an internationally recognized analytical scientist and an accomplished scientific team builder and mentor, having led successful biomarker, analytical, and drug discovery teams. He is an author on ~80 publications focused on disease biology, pharmacology, and analytical sciences and has collaborated with leading global academic groups in the understanding of the mechanisms and physiology of metabolism-based therapies. He has made translational contributions to Fabrazyme, Myozyme, Idhifa, Tibsovo, Pyrukynd, and Ivosidenib.
Tom received his PhD in Chemistry from The Pennsylvania State University, a MS in Chemistry from Villanova University, and a BS in Chemistry from Juniata College.
Metabolomics: a Powerful and Efficient Tool for Drug Discovery and Development
Monday, October 23, 2023
10:00 AM – 10:30 AM ET